Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-15-010391
Filing Date
2015-05-15
Accepted
2015-05-15 16:06:16
Documents
13
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K erb20141231_10k.htm 10-K 1712504
2 EXHIBIT 21.1 ex21-1.htm EX-21.1 6591
3 EXHIBIT 23.1 ex23-1.htm EX-23.1 4370
4 EXHIBIT 31.1 ex31-1.htm EX-31.1 15026
5 EXHIBIT 31.2 ex31-2.htm EX-31.2 15386
6 EXHIBIT 32.1 ex32-1.htm EX-32.1 5964
7 EXHIBIT 32.2 ex32-2.htm EX-32.2 5882
  Complete submission text file 0001437749-15-010391.txt   10168294

Data Files

Seq Description Document Type Size
8 EXHIBIT 101.INS erb-20141231.xml EX-101.INS 1560513
9 EXHIBIT 101.SCH erb-20141231.xsd EX-101.SCH 58610
10 EXHIBIT 101.CAL erb-20141231_cal.xml EX-101.CAL 55272
11 EXHIBIT 101.DEF erb-20141231_def.xml EX-101.DEF 339382
12 EXHIBIT 101.LAB erb-20141231_lab.xml EX-101.LAB 451761
13 EXHIBIT 101.PRE erb-20141231_pre.xml EX-101.PRE 336082
Mailing Address 2140 NORTH MIAMI AVENUE MIAMI FL 33127
Business Address 2140 NORTH MIAMI AVENUE MIAMI FL 33127 305-324-2300
ERBA Diagnostics, Inc. (Filer) CIK: 0001095858 (see all company filings)

EIN.: 113500746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-14798 | Film No.: 15869254
SIC: 2834 Pharmaceutical Preparations